CASI Pharmaceuticals Inc (CASI) — Long-term Investment Intensity
CASI Pharmaceuticals Inc (CASI) has a Long-term Investment Intensity of 7.0% as of September 2025. Long-term investments of $1.72 Million represent 7.0% of total assets of $24.46 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check CASI Pharmaceuticals Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
CASI Pharmaceuticals Inc Long-term Investment Intensity (2019–2024)
This chart shows how CASI Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the intensity stands at 7.0%, reflecting long-term investments of $1.72 Million against total assets of $24.46 Million USD. For the complete balance sheet picture, see how large is CASI Pharmaceuticals Inc's balance sheet.
Annual Long-term Investment Intensity for CASI Pharmaceuticals Inc (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for CASI Pharmaceuticals Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of CASI Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 3.2% | $1.72 Million | $53.67 Million | ▲ +1.0 pp |
| 2023 | 2.2% | $1.68 Million | $75.27 Million | ▼ -5.5 pp |
| 2022 | 7.8% | $7.46 Million | $96.23 Million | ▼ -21.3 pp |
| 2021 | 29.0% | $40.13 Million | $138.30 Million | ▲ +6.0 pp |
| 2020 | 23.0% | $29.44 Million | $127.73 Million | ▲ +9.4 pp |
| 2019 | 13.7% | $14.04 Million | $102.63 Million | — |